FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

ViroPharma stock surges on Vancocin price hike

Tools

ViroPharma's stock surged yesterday after the company announced its third double-digit price hike on Vancocin since it acquired the antibiotic last December. A 20-unit package of Vancocin will now cost $242.10, up from $195.76. Wall Street loves higher prices for drugs and bid up ViroPharma stock by more than 30 percent. ViroPharma paid Eli Lilly $116 million plus royalties for the drug.

- read this AP report for more


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Eli Lilly   antibiotic   Viropharma   Mergers and Acquisitions   pharmaceuticals